DXCM DEXCOM INC.

Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day

This World Diabetes Day, (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first step to discover what they’re made of. This comes as global data1 shows nearly 70% of people with diabetes say they didn’t know where to begin their health journey when they were first diagnosed, and nearly half said diabetes has limited their ability to pursue a passion or interest.

This press release features multimedia. View the full release here:

Dexcom is teaming up with its thousands of global brand advocates – Dexcom Warriors and Stelo Ambassadors, including Nick Jonas, Lance Bass, Retta, Ed Gamble, Molly Sandén and more – to inspire and motivate people with all types of diabetes to take the first step toward discovering what they’re made of. (Photo: Business Wire)

Dexcom is teaming up with its thousands of global brand advocates – Dexcom Warriors and Stelo Ambassadors, including Nick Jonas, Lance Bass, Retta, Ed Gamble, Molly Sandén and more – to inspire and motivate people with all types of diabetes to take the first step toward discovering what they’re made of. (Photo: Business Wire)

For National Diabetes Awareness Month in the U.S. and Canada (November) and on World Diabetes Day (Nov. 14), Dexcom is teaming up with its thousands of global brand advocates – and Stelo Ambassadors, including Nick Jonas, Lance Bass, Retta, Ed Gamble, Molly Sandén and more – to invite people with diabetes to share something they're striving toward on social media – whether it be a new goal, new habit, new beginning or new adventure. By bringing this community together, Dexcom aims to inspire and motivate people with all types of diabetes to take the first step toward discovering what they’re made of.

As part of the campaign, Dexcom surveyed people with diabetes around the world (U.S., U.K., Germany, Poland, Canada, Japan, Netherlands, Australia and New Zealand) and found that 85% of respondents believe that taking small steps to managing diabetes can lead to significant improvements in overall wellbeing. In addition, 84% of current tech users say that technology, such as a CGM or a glucose biosensor, can help those managing diabetes achieve their dreams.

This new data further emphasizes the importance of technology in helping people better manage their diabetes and demonstrates the significance of Dexcom’s relentless commitment to innovation. The company recently added to its portfolio of products with the launch of award-winning2 Stelo, the first over-the-counter glucose biosensor in the U.S., and Dexcom ONE+, the latest CGM system in Europe using Dexcom’s best-in-class sensor platform. Both of these product launches help improve access to life-changing CGM and glucose biosensing, giving even more people with diabetes the peace of mind they need to achieve their dreams.

“At Dexcom, we know better health empowers us all, and I believe World Diabetes Day is the perfect time to change the perception of what’s possible,” said Kevin Sayer, president and chief executive officer at Dexcom. “Our community of users, caregivers, and physicians have inspired us—and we hope that by delivering critical health information across our portfolio of leading glucose biosensors we’re able to do the same. As we build on our legacy of pioneering this industry, we’re committed to helping people at any age and any stage of diabetes receive the information and tools they need to discover what they’re made of.”

“A diabetes diagnosis can feel isolating. With the right support and tools, like Dexcom biosensing technology, it doesn't have to be," said Nick Jonas, multi-platinum recording artist, songwriter, actor and philanthropist. “I'm part of a community that's living proof of what people with all types of diabetes can achieve, and this World Diabetes Day, we hope to inspire others around the world to truly discover what they're made of—and embrace their full potential to live beyond their diagnoses."

In the U.S., Dexcom is hosting a giveaway to inspire people with diabetes to take their first step towards a goal, habit or journey to change their perception of what’s possible. During the month of November, people with diabetes are invited to share their aspirations, small or large. Whether it’s logging the first mile for a 5K run, committing to learn a new language or signing up for a cooking class, every journey starts with taking the first step to discover what you’re made of. Dexcom will help empower that first step by randomly selecting participants to win a $500 prize to jumpstart their journey.

To join the conversation this National Diabetes Awareness Month and World Diabetes Day, share #DiscoverWithDexcom on Instagram and TikTok. Dexcom and Stelo users can enter the U.S. giveaway by visiting or .

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit .

Survey Methodology

Dexcom surveyed 2,250 individuals over the age of 18 living with Type 1 or Type 2 diabetes. 250 individuals were sourced from each of the following markets: Australia, Canada, Germany, Japan, the Netherlands, New Zealand, Poland, the UK and the US. The survey was fielded in October 2024 using Forsta, and panel was sourced from ResearchDesk by RepData.

1 Dexcom, data on file, 2024.

2 (2024). , TIME.

EN
14/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

 PRESS RELEASE

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medi...

EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East." The report surveyed over 2,500 people, made up of individuals with Type 2 diabetes and healthcare professionals, from Germany, Italy, the Netherlands, Saudi Arabia, Spain and the United Kingdom. The findings provide valuable insights into access to care and perceptions of diabetes technology. During the conference, first-ever accuracy a...

Research Team ACF
  • Research Team ACF

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innov...

Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...

 PRESS RELEASE

Dexcom Appoints Renée Galá to Board of Directors

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March 6, 2025. Ms. Galá is an accomplished executive with significant financial, strategic and operational leadership experience across the life sciences sector. She currently serves as President and Chief Operating Officer of Jazz Pharmaceuticals Public Limited Company, a global biopharmaceutical company with greater than $4 billion in total revenues in 2024 whose purpose is to innovate to transform the lives of p...

 PRESS RELEASE

Dexcom Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ:DXCM) today announced that management will present an update on the company at the 46th Annual Raymond James Institutional Investors Conference on Tuesday, March 4th. The live presentation is scheduled to begin at approximately 10:25 AM EST and will be concurrently webcast. Links to the webcast will be available on the Dexcom Investor Relations website at and will be archived there for future reference. About DexCom, Inc. Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneere...

 PRESS RELEASE

Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Revenue grew 8% year-over-year to $1.114 billion on a reported basis and 8% year-over-year on an organic1 basis. U.S. revenue grew 4% and international revenue grew 17% on a reported basis and 19% on an organic1 basis, all on a year-over-year basis. GAAP operating income of $188.9 million or 17.0% of revenue, a decrease of 400 basis points compared to the fourth quarter of 2023. Non-...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch